METEX.PA
METabolic EXplorer S.A. [METEX.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
METEX.PA Stock Summary
Top 10 Correlated Stocks
METEX.PA
In the News
METEX.PA Financial details
Company Rating
Buy
Market Cap
9.13M
Income
-67.76M
Revenue
359M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
450
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-0.36
Forward P/E
-
PEG
-0.1
P/S
0.09
P/B
0.18
P/C
-
P/FCF
-0.38
Quick Ratio
0.46
Current Ratio
1.34
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.55
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
227.77%
Revenue Q/Q
-8.46%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-23%
ROE
-39%
ROC
-0.32%
Gross Margin
-1%
Oper. Margin
-19%
Profit Margin
-22%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.13-1.224
52W High
-
52W Low
-
RSI
42
Rel Volume
0.14
Avg Volume
213.79K
Volume
29.24K
Perf Week
-4.53%
Perf Month
-53.31%
Perf Quarter
-23.62%
Perf Half Y
-22.25%
-
-
-
-
Beta
1.16
-
-
Volatility
0.01%, 0.08%
Prev Close
-0.57%
Price
0.173
Change
-3.57%
METEX.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.01 | 0 | 4.56 | 5.07 | 0 | |
| Net income per share | -0.35 | -0.32 | 2.22 | -1.14 | 0 | |
| Operating cash flow per share | -0.32 | -0.38 | 0.1 | -0.92 | 0 | |
| Free cash flow per share | -1.01 | -1.22 | -0.32 | -1.28 | 0 | |
| Cash per share | 1.12 | 0.65 | 1.16 | 0.3 | 0 | |
| Book value per share | 1.32 | 1.06 | 4.18 | 2.32 | 0 | |
| Tangible book value per share | 1.24 | 1.18 | 3.71 | 1.99 | 0 | |
| Share holders equity per share | 1.32 | 1.06 | 4.18 | 2.32 | 0 | |
| Interest debt per share | 0.3 | 0.52 | 0.79 | 1.26 | 0 | |
| Market cap | 36.68M | 66.36M | 247.43M | 54.09M | 0 | |
| Enterprise value | 26.29M | 71.52M | 248.23M | 92.47M | 0 | |
| P/E ratio | -4.45 | -7.43 | 2.99 | -1.06 | 0 | |
| Price to sales ratio | 104.81 | 1.33K | 1.46 | 0.24 | 0 | |
| POCF ratio | -4.74 | -6.25 | 64.4 | -1.32 | 0 | |
| PFCF ratio | -1.52 | -1.96 | -20.9 | -0.95 | 0 | |
| P/B Ratio | 1.17 | 2.24 | 1.59 | 0.52 | 0 | |
| PTB ratio | 1.17 | 2.24 | 1.59 | 0.52 | 0 | |
| EV to sales | 75.11 | 1.43K | 1.46 | 0.41 | 0 | |
| Enterprise value over EBITDA | -3.1 | -6.24 | -19.22 | -2.44 | 0 | |
| EV to operating cash flow | -3.4 | -6.74 | 64.61 | -2.25 | 0 | |
| EV to free cash flow | -1.09 | -2.11 | -20.97 | -1.62 | 0 | |
| Earnings yield | -0.22 | -0.13 | 0.33 | -0.94 | 0 | |
| Free cash flow yield | -0.66 | -0.51 | -0.05 | -1.05 | 0 | |
| Debt to equity | 0.22 | 0.49 | 0.18 | 0.5 | 0 | |
| Debt to assets | 0.11 | 0.18 | 0.11 | 0.23 | 0 | |
| Net debt to EBITDA | 1.23 | -0.45 | -0.06 | -1.01 | 0 | |
| Current ratio | 3.17 | 1.83 | 2.25 | 1.34 | 0 | |
| Interest coverage | -50.55 | -47.09 | -15.21 | -10.84 | 0 | |
| Income quality | 0.94 | 1.19 | 0.05 | 0.81 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 7.02 | 55.44 | 0.07 | 0.07 | 0 | |
| Research and developement to revenue | 15.58 | 122.54 | 0.05 | 0.04 | 0 | |
| Intangibles to total assets | 0.23 | 0.19 | 0.06 | 0.07 | 0 | |
| Capex to operating cash flow | 2.12 | 2.2 | -4.08 | 0.39 | 0 | |
| Capex to revenue | -46.91 | -466.3 | -0.09 | -0.07 | 0 | |
| Capex to depreciation | -8.74 | -36.77 | -4.84 | -1.93 | 0 | |
| Stock based compensation to revenue | 0.82 | 3.64 | 0.01 | 0 | 0 | |
| Graham number | 3.2 | 2.76 | 14.45 | 7.7 | 0 | |
| ROIC | -0.21 | -0.23 | -0.1 | -0.29 | 0 | |
| Return on tangible assets | -0.17 | -0.14 | 0.35 | -0.24 | 0 | |
| Graham Net | 0.37 | -0.34 | 0.06 | -1.39 | 0 | |
| Working capital | 20.92M | 11.44M | 79.69M | 29.11M | 0 | |
| Tangible asset value | 29.55M | 32.81M | 137.88M | 88.97M | 0 | |
| Net current asset value | 10.83M | -5.73M | 44.99M | -4.8M | 0 | |
| Invested capital | 0.22 | 0.49 | 0.18 | 0.5 | 0 | |
| Average receivables | 1.49M | 3.52M | 23.44M | 35.4M | 14.13M | |
| Average payables | 1.2M | 1.66M | 23.25M | 42.38M | 20.31M | |
| Average inventory | 0.5 | 84.5K | 25.72M | 49.41M | 23.77M | |
| Days sales outstanding | 2.83K | 31.57K | 91.54 | 45.5 | 0 | |
| Days payables outstanding | -173.4 | 368.58 | 104.83 | 65.01 | 0 | |
| Days of inventory on hand | 0 | 26.29 | 121.76 | 76.11 | 0 | |
| Receivables turnover | 0.13 | 0.01 | 3.99 | 8.02 | 0 | |
| Payables turnover | -2.1 | 0.99 | 3.48 | 5.61 | 0 | |
| Inventory turnover | -1.99M | 13.88 | 3 | 4.8 | 0 | |
| ROE | -0.26 | -0.3 | 0.53 | -0.49 | 0 | |
| Capex per share | -0.69 | -0.84 | -0.42 | -0.36 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.98 | 3.47 | 2.19 | 1.36 | 0 | |
| Net income per share | 0.12 | -0.49 | -0.73 | -0.33 | 0 | |
| Operating cash flow per share | -0.08 | -0.8 | -0.25 | -0.61 | 0 | |
| Free cash flow per share | -0.26 | -1 | -0.44 | -0.76 | 0 | |
| Cash per share | 0.97 | 0.5 | 0.3 | 0.94 | 0 | |
| Book value per share | 3.51 | 3.64 | 2.33 | 1.87 | 0 | |
| Tangible book value per share | 3.12 | 3.23 | 2 | 1.58 | 0 | |
| Share holders equity per share | 3.51 | 3.64 | 2.33 | 1.87 | 0 | |
| Interest debt per share | 0.65 | 1.26 | 1.2 | 2.33 | 0 | |
| Market cap | 297.05M | 84.61M | 53.84M | 56.52M | 0 | |
| Enterprise value | 297.85M | 123.59M | 92.23M | 124.97M | 0 | |
| P/E ratio | 13.83 | -1.15 | -0.42 | -0.83 | 0 | |
| Price to sales ratio | 2.23 | 0.65 | 0.55 | 0.82 | 0 | |
| POCF ratio | -84.36 | -2.83 | -4.81 | -1.83 | 0 | |
| PFCF ratio | -25.23 | -2.26 | -2.74 | -1.46 | 0 | |
| P/B Ratio | 1.89 | 0.63 | 0.52 | 0.59 | 0 | |
| PTB ratio | 1.89 | 0.63 | 0.52 | 0.59 | 0 | |
| EV to sales | 2.24 | 0.96 | 0.95 | 1.81 | 0 | |
| Enterprise value over EBITDA | -73.63 | -17.43 | -3.25 | -11.23 | 0 | |
| EV to operating cash flow | -84.59 | -4.13 | -8.24 | -4.05 | 0 | |
| EV to free cash flow | -25.3 | -3.31 | -4.69 | -3.24 | 0 | |
| Earnings yield | 0.02 | -0.22 | -0.6 | -0.3 | 0 | |
| Free cash flow yield | -0.04 | -0.44 | -0.37 | -0.68 | 0 | |
| Debt to equity | 0.18 | 0.32 | 0.5 | 1.22 | 0 | |
| Debt to assets | 0.11 | 0.16 | 0.23 | 0.45 | 0 | |
| Net debt to EBITDA | -0.2 | -5.5 | -1.35 | -6.15 | 0 | |
| Current ratio | 2.25 | 1.71 | 1.34 | 2.19 | 0 | |
| Interest coverage | -8.85 | -4.61 | -22.4 | -6.43 | 0 | |
| Income quality | -0.66 | 1.62 | 0.35 | 1.83 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.05 | 0.05 | 0.09 | 0.11 | 0 | |
| Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.06 | 0 | |
| Intangibles to total assets | 0.06 | 0.06 | 0.07 | 0.06 | 0 | |
| Capex to operating cash flow | 2.34 | 0.25 | 0.76 | 0.25 | 0 | |
| Capex to revenue | -0.06 | -0.06 | -0.09 | -0.11 | 0 | |
| Capex to depreciation | -4.6 | -1.19 | -4.27 | -1.76 | 0 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0.01 | 0 | |
| Graham number | 3.08 | 6.36 | 6.18 | 3.74 | 0 | |
| ROIC | 0.04 | -0.09 | -0.18 | -0.07 | 0 | |
| Return on tangible assets | 0.02 | -0.07 | -0.15 | -0.07 | 0 | |
| Graham Net | 0.08 | -0.98 | -1.4 | -1.28 | 0 | |
| Working capital | 79.69M | 66.28M | 29.11M | 80.32M | 0 | |
| Tangible asset value | 139.38M | 120.19M | 88.97M | 80.32M | 0 | |
| Net current asset value | 46.49M | 28.29M | -4.8M | -15.65M | 0 | |
| Invested capital | 0.18 | 0.32 | 0.5 | 1.22 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 28.77 | 29.92 | 26.12 | 35.45 | 0 | |
| Days payables outstanding | 33.78 | 47.94 | 34.23 | 35.78 | 0 | |
| Days of inventory on hand | 39.24 | 66.17 | 40.07 | 79.07 | 0 | |
| Receivables turnover | 3.13 | 3.01 | 3.45 | 2.54 | 0 | |
| Payables turnover | 2.66 | 1.88 | 2.63 | 2.52 | 0 | |
| Inventory turnover | 2.29 | 1.36 | 2.25 | 1.14 | 0 | |
| ROE | 0.03 | -0.14 | -0.31 | -0.18 | 0 | |
| Capex per share | -0.18 | -0.2 | -0.19 | -0.15 | 0 |
METEX.PA Frequently Asked Questions
What is METabolic EXplorer S.A. stock symbol ?
METabolic EXplorer S.A. is a FR stock and trading under the symbol METEX.PA
What is METabolic EXplorer S.A. stock quote today ?
METabolic EXplorer S.A. stock price is $0.173 today.
Is METabolic EXplorer S.A. stock public?
Yes, METabolic EXplorer S.A. is a publicly traded company.
Company Profile
- Volume Average 213.79K
- Market Capitalization 9.13M
- Employee 450
- CEO Mr. Benjamin Gonzalez
- Headquarters Saint-Beauzire,FR
- IPO Date 2007-04-11
-
Website
https://www.metabolic-explorer.com 
METabolic EXplorer S.A. engages in the development and industrial of industrial fermentation processes as alternatives to petrochemical processes worldwide. Its products are used in animal nutrition and health, textiles, and polymers industries. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
